1. ScholarBank@NUS

XXX Folefac Aminkeng

rp62345

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
XXX Folefac Aminkeng
(not current staff)
Main Affiliation
 
Faculty
 
Email
mdcfa@nus.edu.sg
 

Publications

Results 41-47 of 47 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
11-Sep-2016Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicityAminkeng, Folefac ; Ross, Colin JD; Rassekh, Shahrad R; Hwang, Soomi; Rieder, Michael J; Bhavsar, Amit P; Smith, Anne ; Sanatani, Shubhayan; Gelmon, Karen A; Bernstein, Daniel; Hayden, Michael R; Amstutz, Ursula; Carleton, Bruce C
213-Oct-2021Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patientsHuang, Yiqing; Soon, Yu Yang ; Aminkeng, Folefac ; Tay, Sen Hee ; Ang, Yvonne; Kee, Adrian CL ; Goh, Boon Cher ; Wong, Alvin SC; Soo, Ross A 
3Mar-2021Risk Factors for Immune-Related Adverse Events from Anti-PD-1/PD-L1 Treatment in an Asian Cohort of NSCLC PatientsHuang, Y; Soon, YY; Aminkeng, F ; Tay, SH; Ang, Y; Goh, BC; Wong, A; Soo, RA 
41-Jul-2014The emerging era of pharmacogenomics: current successes, future potential, and challengesLee, JW; Aminkeng, F ; Bhavsar, AP; Shaw, K; Carleton, BC; Hayden, MR; Ross, CJD
51-Aug-2007TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQAminkeng, Folefac ; Van Autreve, Jan E; Koeleman, Bobby PC; Quartier, Erik; Van Schravendijk, Chris; Gorus, Frans K; Van der Auwera, Bart JR
61-Jun-2014Using pharmacogenetics in real time to guide therapy: the warfarin exampleAminkeng, F 
71-Sep-2013WDR45 mutations define a novel disease entity - Static Encephalopathy of Childhood with Neurodegeneration in AdulthoodAminkeng, F